ArticleClinics in shoulder and elbow2025
Effectiveness of a combined arthroscopic and antibiotic-impregnated bead approach for septic shoulder arthritis management: a case series.
Article in Clinics in shoulder and elbow, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study sought to evaluate the effectiveness of a combined treatment approach for septic shoulder arthritis involving arthroscopic synovectomy and use of antibiotic-impregnated polymethylmethacrylate (PMMA) beads for localized antibiotic delivery.
methodsThis retrospective study included 22 patients with septic shoulder arthritis treated at our institution between 2017 and 2023. The treatment involved arthroscopic lavage, debridement, and insertion of antibiotic-impregnated PMMA beads. Patients were evaluated preoperatively and postoperatively based on laboratory tests, imaging, joint fluid analysis, and physical examination. Treatment efficacy was assessed based on normalization of C-reactive protein (CRP) levels, pain reduction as measured using a visual analog scale (VAS), and improvement in shoulder function according to Constant-Murley score.
resultsAll 22 patients demonstrated successful resolution of infection, with only one case of recurrence, leading to a notably low recurrence rate of 5%. Recurrence was determined based on clinical signs (aggravated pain, swelling, and fever) and laboratory markers (elevated CRP and white blood cell count). Mean follow-up duration was 20.2 months. Significant reductions in pain (average VAS score reduction from 8.1 to 2.4, P<0.001) were observed, and mean Constant-Murley score at final follow-up was 60.7, reflecting improved shoulder function.
conclusionsArthroscopic debridement combined with localized antibiotic delivery using PMMA beads is an effective and safe treatment for septic shoulder arthritis. This method offers substantial advantages over traditional treatments, as evidenced by the very low recurrence rate. Level of evidence: IV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.